RxDoctor Payments Data

Sameh Wahba

Psychiatry · Port Jefferson, NYNPI 1154544567

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,000 of the $9,676 with a category attached, or 62.0%. 17 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 43.9% of the total. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,676in general payments, 2019–2025

Across 123 payments — averaging $78.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$4K
  • AbbVie$3K
  • Johnson & Johnson$689
  • Avanir Pharmaceuticals, Inc.$376
  • Otsuka America Pharmaceutical, Inc.$317
  • Lundbeck LLC$282
  • plus $1K from 11 others

What the payments were for

  • Speaking & faculty fees$6,00062%
  • Travel & lodging$1101%
  • Food & beverage$3,56637%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,676 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Other psychiatry in Port Jefferson

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →